Importantly, IAPs expression in the ERK-MAPKi resistance group including 3 types of brain cancers were associated with sensitivity to EGFR inhibitor, PI3K/MTOR inhibitor and WNT signaling inhibitors. The gene discussed is MTOR; the disease is brain cancer.